Global Exosomes Market Report 2023: Sector to Reach $1.03 Billion by 2030 at a CAGR 37.75% - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Exosomes Market Size, Share & Trends Analysis Report By Product (Kits & Reagents, Services), By Application (Cancer, CVD), By Workflow (Isolation Methods, Downstream Analysis), By End-use, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

The global exosomes market size is projected to reach USD 1.03 billion by 2030, registering a CAGR of 37.75% over the forecast period.

Companies Mentioned

• Danaher Corporation
• Hologic Inc.
• Fujifilm Holdings Corporation
• Lonza
• Miltenyi Biotec
• Bio-Techne Corporation
• Qiagen
• Thermo Fisher Scientific, Inc
• Abcam Plc
• Roosterbio, Inc.

The major factors driving the market include technological advancements in exosome isolation and analytical procedures, growth in government and non-government initiatives for exosome research, and the increasing prevalence of cancer. For instance, according to the World Health Organization (WHO), in 2020 there were about 10 million deaths due to cancer, making it one of the foremost causes of death worldwide.

The industry is anticipated to witness rapid growth, owing to the factors, such as the growing need for the identification of cancer biomarkers, detection of infectious agents, and discovery of treatment options for neurodegenerative & Cardiovascular Diseases (CVDs).

Exosomes released by cells into body fluids display different RNA, protein, and lipid contents in patients with various disease conditions as compared to healthy individuals. Hence, exosomes can be used for the development of diagnostic procedures using biomarker identification.

The rising demand for fast, accurate, and minimally invasive diagnostic procedures, thus, represents a promising opportunity for the growth of exosome applications.

The COVID-19 pandemic led to the disruption of clinical trials investigating the diagnostic and therapeutic potential of exosomes in 2020. In addition, nationwide lockdown restrictions, disruption of supply chains, and diversion of investments toward COVID-19-related products led to a decrease in the research and development activities involving exosomes.

Despite the adverse impact in 2020, the pandemic has opened up several new prospects for the development of COVID-19 vaccines and treatments with the use of exosomes, which, in turn, is expected to boost industry growth over the coming years.

For instance, in March 2021, Cell Guidance Systems, a U.S.-based biotechnology research organization, announced plans for the development of exosome therapeutics for treating COVID-19 disease. Moreover, growth in government and non-government initiatives for exosome research is likely to drive the growth during the study period. For instance, in Jan 2023, Mantra Bio raised funding of USD 9 million to advance the development of its lead-targeted exosome therapeutics program.

Exosomes Market Report Highlights

• The kits & reagents segment held the largest revenue share in 2022. Isolation of extracellular vesicles can be difficult, non-specific, and a tedious process. Hence, key players are launching innovative kits and reagents to broaden the applications of exosomes, which is fueling the segment growth
• By workflow, the downstream analysis segment accounted for the largest share in 2022. Major players are offering various technologically advanced products for increasing the utility of downstream analyses, which can positively affect the segment growth
• The cancer application segment dominated the market in 2022 due to the broad range of applications of exosomes in cancer diagnosis, prognosis, and treatment
• The pharmaceutical & biotechnology companies end-use led industry in 2022 due to a rise in the R&D activities
• North America was the dominant region in 2022 due to the presence of key players, rising government funding for the detection of new biomarkers, and high incidence of chronic conditions

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends, & Scope

3.1 Parent Market Analysis

3.2 Market Dynamics

3.2.1 Market Driver Analysis

3.2.1.1 Technological Advancements In Exosomes Isolation And Analytical Procedures

3.2.1.2 Advanced Applications Of Exosomes

3.2.1.3 Growth In Government And Non-Government Initiatives For Exosome Research

3.2.1.4 Increasing Prevalence Of Cancer

3.2.2 Market Restraint Analysis

3.2.2.1 Stringent Regulations Pertaining To Approval

3.2.2.1 Challenges Associated With Implementation Of Exosome-Based Therapies

3.3 Penetration & Growth Prospect Mapping

3.4 Exosomes Market - Porter's Analysis

3.5 Exosomes Market - Swot Analysis

3.6 Covid-19 Impact Analysis

Chapter 4 Product Business Analysis

4.1 Exosomes Market-Product Movement Analysis

4.2 Kits & Reagents

4.2.1 Global Kits & Reagents Market, 2018 - 2030 (USD Million)

4.3 Instruments

4.3.1 Global Instruments Market, 2018 - 2030 (USD Million)

4.4 Services

4.4.1 Global Services Market, 2018 - 2030 (USD Million)

Chapter 5 Workflow Business Analysis

Chapter 6 Application Business Analysis

Chapter 7 End-Use Business Analysis

Chapter 8 Regional Business Analysis

Chapter 9 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/r/j9f1ke

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900